ArticleJAAD international2021
Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: A retrospective analysis of 2 U.S. cohorts.
Article in JAAD international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review.International journal of molecular sciences · 2024Pooled it
- Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA.Dermatology and therapy · 2026Article
- Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa.JAMA dermatology · 2026Article
- Presentations of Cutaneous Disease in Various Skin Pigmentations: Hidradenitis Suppurativa.HCA healthcare journal of medicine · 2026Article
- Exploring the Experience of Black Americans Living with Hidradenitis Suppurativa in the United States Healthcare System: A Narrative Review.Dermatology and therapy · 2025Review
- A diverse hidradenitis suppurativa cohort: A retrospective cross-sectional study of 13,130 patients from a large US health care system database from 1995 to 2022.Journal of the American Academy of Dermatology · 2025Article
- Racial Differences in Disease Characteristics of Pediatric Hidradenitis Suppurativa.Pediatric dermatology · 2025Article
- Full spectrum town halls for hidradenitis suppurativa: A model for advancing clinician-patient-researcher engagement in clinical and translational research.Journal of clinical and translational science · 2025Article
- The impact of innate immunity and epigenetics in the pathogenesis of hidradenitis suppurativa.Frontiers in immunology · 2025Review
- Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.The Journal of dermatology · 2024Article
- Decades Delayed in Diagnosis: Hidradenitis Suppurativa and a Review of Barriers to Care.Cureus · 2024Article
- Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis.International journal of women's dermatology · 2024Article
- A Roadmap for a Consensus Human Skin Cell Atlas and Single-Cell Data Standardization.The Journal of investigative dermatology · 2023Review
- Article
- Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits.Biomedicines · 2022Review
- What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.Frontiers in immunology · 2022Article
- Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa.JCI insight · 2021Article
- Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching.Pediatric dermatologyArticle
- Characterizing Disease Severity, Comorbidities, and Treatment Plans in Pediatric Hidradenitis Suppurativa Patients With and Without Obesity: A Cohort and Cross-Sectional Analysis.Pediatric dermatologyArticle
Corrections and comments
- Erratum issuedCorrection.2021
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
backgroundHidradenitis suppurativa (HS) is known to disproportionately affect patients of color; however, there is a paucity of evidence on how its disease profile varies between races and ethnic groups.
objectiveExplore potential race-dependent differences in the disease profile of HS.
methodsA retrospective analysis was conducted on HS patients at Stanford Hospital and Clinics. Data were compared in terms of demographics, disease severity, and healthcare utilization between races in adults identified to have at least 2 encounters coded for HS. Validation was conducted using Optum's de-identified Clinformatics Data Mart Database of national insurance claims.
resultsOur cohorts consisted of 939 HS patients seen at Stanford and 13,885 HS patients taken from the national dataset. Black and Hispanic patients had greater healthcare utilization compared to White patients. In addition, Hispanic patients at our institution also had significantly increased disease severity compared to their White counterparts ( LIMITATIONS: These cohorts may not be representative of the entire HS patient population.
conclusionOur findings suggest that patients of color may have greater healthcare utilization and disease severity compared to other groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.